Immunogenetics

Papers
(The H4-Index of Immunogenetics is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
The KIR2DL1 intermediate upstream element participates in gene activation80
HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma41
Bioinformatic analysis predicts the regulatory function of noncoding SNPs associated with Long COVID-19 syndrome31
Macroevolution of avian T cell receptor C segments using genomic data28
Oncogenic signaling pathway mediated by Notch pathway-related genes induces immunosuppression and immunotherapy resistance in hepatocellular carcinoma26
Fever as an evolutionary agent to select immune complexes interfaces25
Computational identification and characterization of antigenic properties of Rv3899c of Mycobacterium tuberculosis and its interaction with human leukocyte antigen (HLA)22
Evolution of SARS-CoV-2-specific CD4+ T cell epitopes21
The evolution of innate immune receptors: investigating the diversity, distribution, and phylogeny of immune recognition across eukaryotes20
Dynamic evolution of Mhc haplotypes in cynomolgus macaques of different geographic origins17
Prognostic implication and immunotherapy response prediction of a costimulatory molecule signature in kidney renal clear cell carcinoma16
Concise review: The heterogenous roles of BATF3 in cancer oncogenesis and dendritic cells and T cells differentiation and function considering the importance of BATF3-dependent dendritic cells15
Regulation of genes involved in the metabolic adaptation of murine microglial cells in response to elevated HIF-1α mediated activation15
Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy15
C. elegans: out on an evolutionary limb14
Correction to: SNHG3 regulates NEIL3 via transcription factor E2F1 to mediate malignant proliferation of hepatocellular carcinoma14
0.059565782546997